Sign In
Buy BEAT
$0.710
-0.0495 (-6.52%)
At Close: Jun 22, 2026
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
08:00am, Tuesday, 02'nd Jun 2026
[url="]HeartBeam, Inc.[/url] (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today an
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
07:00am, Tuesday, 02'nd Jun 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home.
HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know
01:01pm, Wednesday, 27'th May 2026
HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
HeartBeam Reports First Quarter 2026 Results
04:01pm, Wednesday, 13'th May 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2026 Results.
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
08:31am, Monday, 11'th May 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic.
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
08:31am, Thursday, 07'th May 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice.
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time
08:31am, Thursday, 30'th Apr 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time.
Insider Buying: HeartBeam (NASDAQ:BEAT) Director Purchases $600,000.00 in Stock
04:36am, Sunday, 19'th Apr 2026
HeartBeam, Inc. (NASDAQ: BEAT - Get Free Report) Director Mark Strome acquired 750,000 shares of the firm's stock in a transaction dated Thursday, April 16th. The stock was bought at an average price
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
04:05pm, Thursday, 16'th Apr 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Closing of $10 Million Public Offering of Common Stock.
Head to Head Contrast: HeartBeam (NASDAQ:BEAT) versus Enovis (NYSE:ENOV)
02:26am, Wednesday, 15'th Apr 2026
HeartBeam (NASDAQ: BEAT - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on th
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
10:00pm, Tuesday, 14'th Apr 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock.
HeartBeam Announces Proposed Public Offering of Common Stock
04:05pm, Tuesday, 14'th Apr 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Proposed Public Offering of Common Stock.
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
09:30am, Friday, 27'th Mar 2026
/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the
HeartBeam, Inc. (BEAT) Q4 2025 Earnings Call Transcript
09:42pm, Thursday, 12'th Mar 2026
HeartBeam, Inc. (BEAT) Q4 2025 Earnings Call Transcript
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
04:01pm, Thursday, 12'th Mar 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2025 Results.
